+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Autoimmune Treatment Market Research Report by Product (Diagnostic Equipment, Drugs, and Therapeutic & Monitoring Equipment), Application, Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) - Global Forecast to 2027 - Cumulative Impact of COVID-19

  • PDF Icon

    Report

  • 250 Pages
  • July 2022
  • Region: Global
  • 360iResearch™
  • ID: 4995356
UP TO OFF until Dec 31st 2022
The Global Autoimmune Treatment Market size was estimated at USD 171.58 billion in 2021, USD 184.67 billion in 2022, and is projected to grow at a CAGR 7.80% to reach USD 269.33 billion by 2027.

Market Statistics:


The report provides market sizing and forecast across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2019 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.

Market Segmentation & Coverage:


This research report categorizes the Autoimmune Treatment to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Product, the market was studied across Diagnostic Equipment, Drugs, and Therapeutic & Monitoring Equipment. The Drugs is further studied across Aminosalicylates/5-asa/Mesalazine, Anthralin, Avonex, Betaseron, Calicipotriene, Copaxone, Corticosteriods, Glucocorticoids, Hydroxychloroquine (HCQ), Methotrexate, Non-steroidal Anti-inflammatory Drugs (NSAID), and Rebif.
  • Based on Application, the market was studied across Localized Autoimmune Diseases and Systemic Autoimmune Diseases.
  • Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:


COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:


We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Autoimmune Treatment market considering the current update on the conflict and its global response.

Competitive Strategic Window:


The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:


The FPNV Positioning Matrix evaluates and categorizes the vendors in the Autoimmune Treatment Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:


The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:


The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:


The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Autoimmune Treatment Market, including Abbott Laboratories, AbbVie Inc, Active Biotech, Amgen Inc., Angiotech Pharmaceuticals, Astellas Pharma Inc, AstraZeneca PLC, Autoimmune Inc, Bayer AG, Bio-rad Laboratories, Biocryst Pharmaceuticals Inc., Biogen Inc, Biomérieux SA, Bristol-Myers Squibb, C.H. Boehringer Sohn AG & Ko. KG, F. Hoffmann-la Roche, GlaxoSmithKline PLC, Inova Diagnostics, Inc. by Werfen Group, Johnson & Johnson Services, Inc, Lupin Limited, Myriad Genetics, Novartis AG, Pandion Therapeutics, Pfizer Inc., SC AG, Siemens Healthineers, Inc., Thermo Fisher Scientific, Inc, and Trinity Biotech PLC.

The report provides insights on the following pointers:


1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:


1. What is the market size and forecast of the Global Autoimmune Treatment Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Autoimmune Treatment Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Autoimmune Treatment Market?
4. What is the competitive strategic window for opportunities in the Global Autoimmune Treatment Market?
5. What are the technology trends and regulatory frameworks in the Global Autoimmune Treatment Market?
6. What is the market share of the leading vendors in the Global Autoimmune Treatment Market?
7. What modes and strategic moves are considered suitable for entering the Global Autoimmune Treatment Market?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing prevalence of autoimmune diseases in emerging economies
5.1.1.2. Rapidly improvement in healthcare infrastructure coupled with rising patient awareness levels
5.1.1.3. Urbanization and availability of high disposable income with the population
5.1.2. Restraints
5.1.2.1. High cost and uncertain outcomes of the treatment
5.1.3. Opportunities
5.1.3.1. Increasing funding by government associations and non-profit organizations for development of new drugs and therapies
5.1.3.2. Automation of laboratories to ease several autoimmune diagnostic tests and availability of autoimmune treatments
5.1.4. Challenges
5.1.4.1. Slow turnaround time associated with the autoimmune disease diagnostics procedures
5.2. Cumulative Impact of COVID-19
6. Autoimmune Treatment Market, by Product
6.1. Introduction
6.2. Diagnostic Equipment
6.3. Drugs
6.3.1. Aminosalicylates/5-asa/Mesalazine
6.3.2. Anthralin
6.3.3. Avonex
6.3.4. Betaseron
6.3.5. Calicipotriene
6.3.6. Copaxone
6.3.7. Corticosteriods
6.3.8. Glucocorticoids
6.3.9. Hydroxychloroquine (HCQ)
6.3.10. Methotrexate
6.3.11. Non-steroidal Anti-inflammatory Drugs (NSAID)
6.3.12. Rebif
6.4. Therapeutic & Monitoring Equipment
7. Autoimmune Treatment Market, by Application
7.1. Introduction
7.2. Localized Autoimmune Diseases
7.3. Systemic Autoimmune Diseases
8. Americas Autoimmune Treatment Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States
9. Asia-Pacific Autoimmune Treatment Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand
10. Europe, Middle East & Africa Autoimmune Treatment Market
10.1. Introduction
10.2. France
10.3. Germany
10.4. Italy
10.5. Netherlands
10.6. Qatar
10.7. Russia
10.8. Saudi Arabia
10.9. South Africa
10.10. Spain
10.11. United Arab Emirates
10.12. United Kingdom
11. Competitive Landscape
11.1. FPNV Positioning Matrix
11.1.1. Quadrants
11.1.2. Business Strategy
11.1.3. Product Satisfaction
11.2. Market Ranking Analysis
11.3. Market Share Analysis, By Key Player
11.4. Competitive Scenario
11.4.1. Merger & Acquisition
11.4.2. Agreement, Collaboration, & Partnership
11.4.3. New Product Launch & Enhancement
11.4.4. Investment & Funding
11.4.5. Award, Recognition, & Expansion
12. Company Usability Profiles
12.1. Abbott Laboratories
12.2. AbbVie Inc
12.3. Active Biotech
12.4. Amgen Inc.
12.5. Angiotech Pharmaceuticals
12.6. Astellas Pharma Inc
12.7. AstraZeneca PLC
12.8. Autoimmune Inc
12.9. Bayer AG
12.10. Bio-rad Laboratories
12.11. Biocryst Pharmaceuticals Inc.
12.12. Biogen Inc
12.13. Biomérieux SA
12.14. Bristol-Myers Squibb
12.15. C.H. Boehringer Sohn AG & Ko. KG
12.16. F. Hoffmann-la Roche
12.17. GlaxoSmithKline PLC
12.18. Inova Diagnostics, Inc. by Werfen Group
12.19. Johnson & Johnson Services, Inc
12.20. Lupin Limited
12.21. Myriad Genetics
12.22. Novartis AG
12.23. Pandion Therapeutics
12.24. Pfizer Inc.
12.25. SC AG
12.26. Siemens Healthineers, Inc.
12.27. Thermo Fisher Scientific, Inc
12.28. Trinity Biotech PLC
13. Appendix
13.1. Discussion Guide
13.2. License & Pricing
List of Figures
FIGURE 1. GLOBAL AUTOIMMUNE TREATMENT MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL AUTOIMMUNE TREATMENT MARKET SIZE, 2021 VS 2027 (USD BILLION)
FIGURE 3. GLOBAL AUTOIMMUNE TREATMENT MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 4. GLOBAL AUTOIMMUNE TREATMENT MARKET SIZE, BY REGION, 2021 VS 2027 (%)
FIGURE 5. GLOBAL AUTOIMMUNE TREATMENT MARKET SIZE, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 6. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL AUTOIMMUNE TREATMENT MARKET SIZE, BY REGION, 2027
FIGURE 7. GLOBAL AUTOIMMUNE TREATMENT MARKET DYNAMICS
FIGURE 8. GLOBAL AUTOIMMUNE TREATMENT MARKET SIZE, BY PRODUCT, 2021 VS 2027 (%)
FIGURE 9. GLOBAL AUTOIMMUNE TREATMENT MARKET SIZE, BY PRODUCT, 2021 VS 2027 (USD BILLION)
FIGURE 10. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL AUTOIMMUNE TREATMENT MARKET SIZE, BY PRODUCT, 2027
FIGURE 11. GLOBAL AUTOIMMUNE TREATMENT MARKET SIZE, BY DIAGNOSTIC EQUIPMENT, 2019-2027 (USD BILLION)
FIGURE 12. GLOBAL AUTOIMMUNE TREATMENT MARKET SIZE, BY DIAGNOSTIC EQUIPMENT, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 13. GLOBAL AUTOIMMUNE TREATMENT MARKET SIZE, BY DRUGS, 2019-2027 (USD BILLION)
FIGURE 14. GLOBAL AUTOIMMUNE TREATMENT MARKET SIZE, BY DRUGS, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 15. GLOBAL AUTOIMMUNE TREATMENT MARKET SIZE, BY AMINOSALICYLATES/5-ASA/MESALAZINE, 2019-2027 (USD BILLION)
FIGURE 16. GLOBAL AUTOIMMUNE TREATMENT MARKET SIZE, BY AMINOSALICYLATES/5-ASA/MESALAZINE, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 17. GLOBAL AUTOIMMUNE TREATMENT MARKET SIZE, BY ANTHRALIN, 2019-2027 (USD BILLION)
FIGURE 18. GLOBAL AUTOIMMUNE TREATMENT MARKET SIZE, BY ANTHRALIN, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 19. GLOBAL AUTOIMMUNE TREATMENT MARKET SIZE, BY AVONEX, 2019-2027 (USD BILLION)
FIGURE 20. GLOBAL AUTOIMMUNE TREATMENT MARKET SIZE, BY AVONEX, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 21. GLOBAL AUTOIMMUNE TREATMENT MARKET SIZE, BY BETASERON, 2019-2027 (USD BILLION)
FIGURE 22. GLOBAL AUTOIMMUNE TREATMENT MARKET SIZE, BY BETASERON, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 23. GLOBAL AUTOIMMUNE TREATMENT MARKET SIZE, BY CALICIPOTRIENE, 2019-2027 (USD BILLION)
FIGURE 24. GLOBAL AUTOIMMUNE TREATMENT MARKET SIZE, BY CALICIPOTRIENE, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 25. GLOBAL AUTOIMMUNE TREATMENT MARKET SIZE, BY COPAXONE, 2019-2027 (USD BILLION)
FIGURE 26. GLOBAL AUTOIMMUNE TREATMENT MARKET SIZE, BY COPAXONE, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 27. GLOBAL AUTOIMMUNE TREATMENT MARKET SIZE, BY CORTICOSTERIODS, 2019-2027 (USD BILLION)
FIGURE 28. GLOBAL AUTOIMMUNE TREATMENT MARKET SIZE, BY CORTICOSTERIODS, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 29. GLOBAL AUTOIMMUNE TREATMENT MARKET SIZE, BY GLUCOCORTICOIDS, 2019-2027 (USD BILLION)
FIGURE 30. GLOBAL AUTOIMMUNE TREATMENT MARKET SIZE, BY GLUCOCORTICOIDS, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 31. GLOBAL AUTOIMMUNE TREATMENT MARKET SIZE, BY HYDROXYCHLOROQUINE (HCQ), 2019-2027 (USD BILLION)
FIGURE 32. GLOBAL AUTOIMMUNE TREATMENT MARKET SIZE, BY HYDROXYCHLOROQUINE (HCQ), BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 33. GLOBAL AUTOIMMUNE TREATMENT MARKET SIZE, BY METHOTREXATE, 2019-2027 (USD BILLION)
FIGURE 34. GLOBAL AUTOIMMUNE TREATMENT MARKET SIZE, BY METHOTREXATE, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 35. GLOBAL AUTOIMMUNE TREATMENT MARKET SIZE, BY NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAID), 2019-2027 (USD BILLION)
FIGURE 36. GLOBAL AUTOIMMUNE TREATMENT MARKET SIZE, BY NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAID), BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 37. GLOBAL AUTOIMMUNE TREATMENT MARKET SIZE, BY REBIF, 2019-2027 (USD BILLION)
FIGURE 38. GLOBAL AUTOIMMUNE TREATMENT MARKET SIZE, BY REBIF, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 39. GLOBAL AUTOIMMUNE TREATMENT MARKET SIZE, BY THERAPEUTIC & MONITORING EQUIPMENT, 2019-2027 (USD BILLION)
FIGURE 40. GLOBAL AUTOIMMUNE TREATMENT MARKET SIZE, BY THERAPEUTIC & MONITORING EQUIPMENT, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 41. GLOBAL AUTOIMMUNE TREATMENT MARKET SIZE, BY APPLICATION, 2021 VS 2027 (%)
FIGURE 42. GLOBAL AUTOIMMUNE TREATMENT MARKET SIZE, BY APPLICATION, 2021 VS 2027 (USD BILLION)
FIGURE 43. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL AUTOIMMUNE TREATMENT MARKET SIZE, BY APPLICATION, 2027
FIGURE 44. GLOBAL AUTOIMMUNE TREATMENT MARKET SIZE, BY LOCALIZED AUTOIMMUNE DISEASES, 2019-2027 (USD BILLION)
FIGURE 45. GLOBAL AUTOIMMUNE TREATMENT MARKET SIZE, BY LOCALIZED AUTOIMMUNE DISEASES, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 46. GLOBAL AUTOIMMUNE TREATMENT MARKET SIZE, BY SYSTEMIC AUTOIMMUNE DISEASES, 2019-2027 (USD BILLION)
FIGURE 47. GLOBAL AUTOIMMUNE TREATMENT MARKET SIZE, BY SYSTEMIC AUTOIMMUNE DISEASES, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 48. AMERICAS AUTOIMMUNE TREATMENT MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 49. AMERICAS AUTOIMMUNE TREATMENT MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 50. AMERICAS AUTOIMMUNE TREATMENT MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD BILLION)
FIGURE 51. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS AUTOIMMUNE TREATMENT MARKET SIZE, BY COUNTRY, 2027
FIGURE 52. ARGENTINA AUTOIMMUNE TREATMENT MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 53. BRAZIL AUTOIMMUNE TREATMENT MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 54. CANADA AUTOIMMUNE TREATMENT MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 55. MEXICO AUTOIMMUNE TREATMENT MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 56. UNITED STATES AUTOIMMUNE TREATMENT MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 57. UNITED STATES AUTOIMMUNE TREATMENT MARKET SIZE, BY STATE, 2021 VS 2027 (%)
FIGURE 58. UNITED STATES AUTOIMMUNE TREATMENT MARKET SIZE, BY STATE, 2021 VS 2027 (USD BILLION)
FIGURE 59. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES AUTOIMMUNE TREATMENT MARKET SIZE, BY STATE, 2027
FIGURE 60. ASIA-PACIFIC AUTOIMMUNE TREATMENT MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 61. ASIA-PACIFIC AUTOIMMUNE TREATMENT MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 62. ASIA-PACIFIC AUTOIMMUNE TREATMENT MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD BILLION)
FIGURE 63. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC AUTOIMMUNE TREATMENT MARKET SIZE, BY COUNTRY, 2027
FIGURE 64. AUSTRALIA AUTOIMMUNE TREATMENT MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 65. CHINA AUTOIMMUNE TREATMENT MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 66. INDIA AUTOIMMUNE TREATMENT MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 67. INDONESIA AUTOIMMUNE TREATMENT MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 68. JAPAN AUTOIMMUNE TREATMENT MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 69. MALAYSIA AUTOIMMUNE TREATMENT MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 70. PHILIPPINES AUTOIMMUNE TREATMENT MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 71. SINGAPORE AUTOIMMUNE TREATMENT MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 72. SOUTH KOREA AUTOIMMUNE TREATMENT MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 73. TAIWAN AUTOIMMUNE TREATMENT MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 74. THAILAND AUTOIMMUNE TREATMENT MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 75. EUROPE, MIDDLE EAST & AFRICA AUTOIMMUNE TREATMENT MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 76. EUROPE, MIDDLE EAST & AFRICA AUTOIMMUNE TREATMENT MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 77. EUROPE, MIDDLE EAST & AFRICA AUTOIMMUNE TREATMENT MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD BILLION)
FIGURE 78. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA AUTOIMMUNE TREATMENT MARKET SIZE, BY COUNTRY, 2027
FIGURE 79. FRANCE AUTOIMMUNE TREATMENT MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 80. GERMANY AUTOIMMUNE TREATMENT MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 81. ITALY AUTOIMMUNE TREATMENT MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 82. NETHERLANDS AUTOIMMUNE TREATMENT MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 83. QATAR AUTOIMMUNE TREATMENT MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 84. RUSSIA AUTOIMMUNE TREATMENT MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 85. SAUDI ARABIA AUTOIMMUNE TREATMENT MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 86. SOUTH AFRICA AUTOIMMUNE TREATMENT MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 87. SPAIN AUTOIMMUNE TREATMENT MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 88. UNITED ARAB EMIRATES AUTOIMMUNE TREATMENT MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 89. UNITED KINGDOM AUTOIMMUNE TREATMENT MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 90. GLOBAL AUTOIMMUNE TREATMENT MARKET: FPNV POSITIONING MATRIX, 2021
FIGURE 91. GLOBAL AUTOIMMUNE TREATMENT MARKET SHARE, BY KEY PLAYER, 2021
FIGURE 92. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL AUTOIMMUNE TREATMENT MARKET, BY TYPE
List of Tables
TABLE 1. GLOBAL AUTOIMMUNE TREATMENT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
TABLE 3. GLOBAL AUTOIMMUNE TREATMENT MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 4. GLOBAL AUTOIMMUNE TREATMENT MARKET SIZE, BY REGION, 2019-2027 (USD BILLION)
TABLE 5. GLOBAL AUTOIMMUNE TREATMENT MARKET SIZE, BY PRODUCT, 2019-2027 (USD BILLION)
TABLE 6. GLOBAL AUTOIMMUNE TREATMENT MARKET SIZE, BY DIAGNOSTIC EQUIPMENT, BY REGION, 2019-2027 (USD BILLION)
TABLE 7. AMERICAS AUTOIMMUNE TREATMENT MARKET SIZE, BY DIAGNOSTIC EQUIPMENT, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 8. UNITED STATES AUTOIMMUNE TREATMENT MARKET SIZE, BY DIAGNOSTIC EQUIPMENT, BY STATE, 2019-2027 (USD BILLION)
TABLE 9. ASIA-PACIFIC AUTOIMMUNE TREATMENT MARKET SIZE, BY DIAGNOSTIC EQUIPMENT, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 10. EUROPE, MIDDLE EAST & AFRICA AUTOIMMUNE TREATMENT MARKET SIZE, BY DIAGNOSTIC EQUIPMENT, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 11. GLOBAL AUTOIMMUNE TREATMENT MARKET SIZE, BY DRUGS, BY REGION, 2019-2027 (USD BILLION)
TABLE 12. AMERICAS AUTOIMMUNE TREATMENT MARKET SIZE, BY DRUGS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 13. UNITED STATES AUTOIMMUNE TREATMENT MARKET SIZE, BY DRUGS, BY STATE, 2019-2027 (USD BILLION)
TABLE 14. ASIA-PACIFIC AUTOIMMUNE TREATMENT MARKET SIZE, BY DRUGS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 15. EUROPE, MIDDLE EAST & AFRICA AUTOIMMUNE TREATMENT MARKET SIZE, BY DRUGS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 16. GLOBAL AUTOIMMUNE TREATMENT MARKET SIZE, BY AMINOSALICYLATES/5-ASA/MESALAZINE, BY REGION, 2019-2027 (USD BILLION)
TABLE 17. AMERICAS AUTOIMMUNE TREATMENT MARKET SIZE, BY AMINOSALICYLATES/5-ASA/MESALAZINE, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 18. UNITED STATES AUTOIMMUNE TREATMENT MARKET SIZE, BY AMINOSALICYLATES/5-ASA/MESALAZINE, BY STATE, 2019-2027 (USD BILLION)
TABLE 19. ASIA-PACIFIC AUTOIMMUNE TREATMENT MARKET SIZE, BY AMINOSALICYLATES/5-ASA/MESALAZINE, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 20. EUROPE, MIDDLE EAST & AFRICA AUTOIMMUNE TREATMENT MARKET SIZE, BY AMINOSALICYLATES/5-ASA/MESALAZINE, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 21. GLOBAL AUTOIMMUNE TREATMENT MARKET SIZE, BY ANTHRALIN, BY REGION, 2019-2027 (USD BILLION)
TABLE 22. AMERICAS AUTOIMMUNE TREATMENT MARKET SIZE, BY ANTHRALIN, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 23. UNITED STATES AUTOIMMUNE TREATMENT MARKET SIZE, BY ANTHRALIN, BY STATE, 2019-2027 (USD BILLION)
TABLE 24. ASIA-PACIFIC AUTOIMMUNE TREATMENT MARKET SIZE, BY ANTHRALIN, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 25. EUROPE, MIDDLE EAST & AFRICA AUTOIMMUNE TREATMENT MARKET SIZE, BY ANTHRALIN, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 26. GLOBAL AUTOIMMUNE TREATMENT MARKET SIZE, BY AVONEX, BY REGION, 2019-2027 (USD BILLION)
TABLE 27. AMERICAS AUTOIMMUNE TREATMENT MARKET SIZE, BY AVONEX, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 28. UNITED STATES AUTOIMMUNE TREATMENT MARKET SIZE, BY AVONEX, BY STATE, 2019-2027 (USD BILLION)
TABLE 29. ASIA-PACIFIC AUTOIMMUNE TREATMENT MARKET SIZE, BY AVONEX, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 30. EUROPE, MIDDLE EAST & AFRICA AUTOIMMUNE TREATMENT MARKET SIZE, BY AVONEX, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 31. GLOBAL AUTOIMMUNE TREATMENT MARKET SIZE, BY BETASERON, BY REGION, 2019-2027 (USD BILLION)
TABLE 32. AMERICAS AUTOIMMUNE TREATMENT MARKET SIZE, BY BETASERON, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 33. UNITED STATES AUTOIMMUNE TREATMENT MARKET SIZE, BY BETASERON, BY STATE, 2019-2027 (USD BILLION)
TABLE 34. ASIA-PACIFIC AUTOIMMUNE TREATMENT MARKET SIZE, BY BETASERON, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 35. EUROPE, MIDDLE EAST & AFRICA AUTOIMMUNE TREATMENT MARKET SIZE, BY BETASERON, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 36. GLOBAL AUTOIMMUNE TREATMENT MARKET SIZE, BY CALICIPOTRIENE, BY REGION, 2019-2027 (USD BILLION)
TABLE 37. AMERICAS AUTOIMMUNE TREATMENT MARKET SIZE, BY CALICIPOTRIENE, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 38. UNITED STATES AUTOIMMUNE TREATMENT MARKET SIZE, BY CALICIPOTRIENE, BY STATE, 2019-2027 (USD BILLION)
TABLE 39. ASIA-PACIFIC AUTOIMMUNE TREATMENT MARKET SIZE, BY CALICIPOTRIENE, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 40. EUROPE, MIDDLE EAST & AFRICA AUTOIMMUNE TREATMENT MARKET SIZE, BY CALICIPOTRIENE, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 41. GLOBAL AUTOIMMUNE TREATMENT MARKET SIZE, BY COPAXONE, BY REGION, 2019-2027 (USD BILLION)
TABLE 42. AMERICAS AUTOIMMUNE TREATMENT MARKET SIZE, BY COPAXONE, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 43. UNITED STATES AUTOIMMUNE TREATMENT MARKET SIZE, BY COPAXONE, BY STATE, 2019-2027 (USD BILLION)
TABLE 44. ASIA-PACIFIC AUTOIMMUNE TREATMENT MARKET SIZE, BY COPAXONE, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 45. EUROPE, MIDDLE EAST & AFRICA AUTOIMMUNE TREATMENT MARKET SIZE, BY COPAXONE, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 46. GLOBAL AUTOIMMUNE TREATMENT MARKET SIZE, BY CORTICOSTERIODS, BY REGION, 2019-2027 (USD BILLION)
TABLE 47. AMERICAS AUTOIMMUNE TREATMENT MARKET SIZE, BY CORTICOSTERIODS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 48. UNITED STATES AUTOIMMUNE TREATMENT MARKET SIZE, BY CORTICOSTERIODS, BY STATE, 2019-2027 (USD BILLION)
TABLE 49. ASIA-PACIFIC AUTOIMMUNE TREATMENT MARKET SIZE, BY CORTICOSTERIODS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 50. EUROPE, MIDDLE EAST & AFRICA AUTOIMMUNE TREATMENT MARKET SIZE, BY CORTICOSTERIODS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 51. GLOBAL AUTOIMMUNE TREATMENT MARKET SIZE, BY GLUCOCORTICOIDS, BY REGION, 2019-2027 (USD BILLION)
TABLE 52. AMERICAS AUTOIMMUNE TREATMENT MARKET SIZE, BY GLUCOCORTICOIDS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 53. UNITED STATES AUTOIMMUNE TREATMENT MARKET SIZE, BY GLUCOCORTICOIDS, BY STATE, 2019-2027 (USD BILLION)
TABLE 54. ASIA-PACIFIC AUTOIMMUNE TREATMENT MARKET SIZE, BY GLUCOCORTICOIDS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 55. EUROPE, MIDDLE EAST & AFRICA AUTOIMMUNE TREATMENT MARKET SIZE, BY GLUCOCORTICOIDS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 56. GLOBAL AUTOIMMUNE TREATMENT MARKET SIZE, BY HYDROXYCHLOROQUINE (HCQ), BY REGION, 2019-2027 (USD BILLION)
TABLE 57. AMERICAS AUTOIMMUNE TREATMENT MARKET SIZE, BY HYDROXYCHLOROQUINE (HCQ), BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 58. UNITED STATES AUTOIMMUNE TREATMENT MARKET SIZE, BY HYDROXYCHLOROQUINE (HCQ), BY STATE, 2019-2027 (USD BILLION)
TABLE 59. ASIA-PACIFIC AUTOIMMUNE TREATMENT MARKET SIZE, BY HYDROXYCHLOROQUINE (HCQ), BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 60. EUROPE, MIDDLE EAST & AFRICA AUTOIMMUNE TREATMENT MARKET SIZE, BY HYDROXYCHLOROQUINE (HCQ), BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 61. GLOBAL AUTOIMMUNE TREATMENT MARKET SIZE, BY METHOTREXATE, BY REGION, 2019-2027 (USD BILLION)
TABLE 62. AMERICAS AUTOIMMUNE TREATMENT MARKET SIZE, BY METHOTREXATE, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 63. UNITED STATES AUTOIMMUNE TREATMENT MARKET SIZE, BY METHOTREXATE, BY STATE, 2019-2027 (USD BILLION)
TABLE 64. ASIA-PACIFIC AUTOIMMUNE TREATMENT MARKET SIZE, BY METHOTREXATE, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 65. EUROPE, MIDDLE EAST & AFRICA AUTOIMMUNE TREATMENT MARKET SIZE, BY METHOTREXATE, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 66. GLOBAL AUTOIMMUNE TREATMENT MARKET SIZE, BY NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAID), BY REGION, 2019-2027 (USD BILLION)
TABLE 67. AMERICAS AUTOIMMUNE TREATMENT MARKET SIZE, BY NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAID), BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 68. UNITED STATES AUTOIMMUNE TREATMENT MARKET SIZE, BY NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAID), BY STATE, 2019-2027 (USD BILLION)
TABLE 69. ASIA-PACIFIC AUTOIMMUNE TREATMENT MARKET SIZE, BY NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAID), BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 70. EUROPE, MIDDLE EAST & AFRICA AUTOIMMUNE TREATMENT MARKET SIZE, BY NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAID), BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 71. GLOBAL AUTOIMMUNE TREATMENT MARKET SIZE, BY REBIF, BY REGION, 2019-2027 (USD BILLION)
TABLE 72. AMERICAS AUTOIMMUNE TREATMENT MARKET SIZE, BY REBIF, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 73. UNITED STATES AUTOIMMUNE TREATMENT MARKET SIZE, BY REBIF, BY STATE, 2019-2027 (USD BILLION)
TABLE 74. ASIA-PACIFIC AUTOIMMUNE TREATMENT MARKET SIZE, BY REBIF, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 75. EUROPE, MIDDLE EAST & AFRICA AUTOIMMUNE TREATMENT MARKET SIZE, BY REBIF, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 76. GLOBAL AUTOIMMUNE TREATMENT MARKET SIZE, BY THERAPEUTIC & MONITORING EQUIPMENT, BY REGION, 2019-2027 (USD BILLION)
TABLE 77. AMERICAS AUTOIMMUNE TREATMENT MARKET SIZE, BY THERAPEUTIC & MONITORING EQUIPMENT, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 78. UNITED STATES AUTOIMMUNE TREATMENT MARKET SIZE, BY THERAPEUTIC & MONITORING EQUIPMENT, BY STATE, 2019-2027 (USD BILLION)
TABLE 79. ASIA-PACIFIC AUTOIMMUNE TREATMENT MARKET SIZE, BY THERAPEUTIC & MONITORING EQUIPMENT, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 80. EUROPE, MIDDLE EAST & AFRICA AUTOIMMUNE TREATMENT MARKET SIZE, BY THERAPEUTIC & MONITORING EQUIPMENT, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 81. GLOBAL AUTOIMMUNE TREATMENT MARKET SIZE, BY APPLICATION, 2019-2027 (USD BILLION)
TABLE 82. GLOBAL AUTOIMMUNE TREATMENT MARKET SIZE, BY LOCALIZED AUTOIMMUNE DISEASES, BY REGION, 2019-2027 (USD BILLION)
TABLE 83. AMERICAS AUTOIMMUNE TREATMENT MARKET SIZE, BY LOCALIZED AUTOIMMUNE DISEASES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 84. UNITED STATES AUTOIMMUNE TREATMENT MARKET SIZE, BY LOCALIZED AUTOIMMUNE DISEASES, BY STATE, 2019-2027 (USD BILLION)
TABLE 85. ASIA-PACIFIC AUTOIMMUNE TREATMENT MARKET SIZE, BY LOCALIZED AUTOIMMUNE DISEASES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 86. EUROPE, MIDDLE EAST & AFRICA AUTOIMMUNE TREATMENT MARKET SIZE, BY LOCALIZED AUTOIMMUNE DISEASES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 87. GLOBAL AUTOIMMUNE TREATMENT MARKET SIZE, BY SYSTEMIC AUTOIMMUNE DISEASES, BY REGION, 2019-2027 (USD BILLION)
TABLE 88. AMERICAS AUTOIMMUNE TREATMENT MARKET SIZE, BY SYSTEMIC AUTOIMMUNE DISEASES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 89. UNITED STATES AUTOIMMUNE TREATMENT MARKET SIZE, BY SYSTEMIC AUTOIMMUNE DISEASES, BY STATE, 2019-2027 (USD BILLION)
TABLE 90. ASIA-PACIFIC AUTOIMMUNE TREATMENT MARKET SIZE, BY SYSTEMIC AUTOIMMUNE DISEASES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 91. EUROPE, MIDDLE EAST & AFRICA AUTOIMMUNE TREATMENT MARKET SIZE, BY SYSTEMIC AUTOIMMUNE DISEASES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 92. AMERICAS AUTOIMMUNE TREATMENT MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 93. AMERICAS AUTOIMMUNE TREATMENT MARKET SIZE, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 94. AMERICAS AUTOIMMUNE TREATMENT MARKET SIZE, BY PRODUCT, 2019-2027 (USD BILLION)
TABLE 95. AMERICAS AUTOIMMUNE TREATMENT MARKET SIZE, BY APPLICATION, 2019-2027 (USD BILLION)
TABLE 96. ARGENTINA AUTOIMMUNE TREATMENT MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 97. ARGENTINA AUTOIMMUNE TREATMENT MARKET SIZE, BY PRODUCT, 2019-2027 (USD BILLION)
TABLE 98. ARGENTINA AUTOIMMUNE TREATMENT MARKET SIZE, BY APPLICATION, 2019-2027 (USD BILLION)
TABLE 99. BRAZIL AUTOIMMUNE TREATMENT MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 100. BRAZIL AUTOIMMUNE TREATMENT MARKET SIZE, BY PRODUCT, 2019-2027 (USD BILLION)
TABLE 101. BRAZIL AUTOIMMUNE TREATMENT MARKET SIZE, BY APPLICATION, 2019-2027 (USD BILLION)
TABLE 102. CANADA AUTOIMMUNE TREATMENT MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 103. CANADA AUTOIMMUNE TREATMENT MARKET SIZE, BY PRODUCT, 2019-2027 (USD BILLION)
TABLE 104. CANADA AUTOIMMUNE TREATMENT MARKET SIZE, BY APPLICATION, 2019-2027 (USD BILLION)
TABLE 105. MEXICO AUTOIMMUNE TREATMENT MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 106. MEXICO AUTOIMMUNE TREATMENT MARKET SIZE, BY PRODUCT, 2019-2027 (USD BILLION)
TABLE 107. MEXICO AUTOIMMUNE TREATMENT MARKET SIZE, BY APPLICATION, 2019-2027 (USD BILLION)
TABLE 108. UNITED STATES AUTOIMMUNE TREATMENT MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 109. UNITED STATES AUTOIMMUNE TREATMENT MARKET SIZE, BY STATE, 2019-2027 (USD BILLION)
TABLE 110. UNITED STATES AUTOIMMUNE TREATMENT MARKET SIZE, BY PRODUCT, 2019-2027 (USD BILLION)
TABLE 111. UNITED STATES AUTOIMMUNE TREATMENT MARKET SIZE, BY APPLICATION, 2019-2027 (USD BILLION)
TABLE 112. ASIA-PACIFIC AUTOIMMUNE TREATMENT MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 113. ASIA-PACIFIC AUTOIMMUNE TREATMENT MARKET SIZE, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 114. ASIA-PACIFIC AUTOIMMUNE TREATMENT MARKET SIZE, BY PRODUCT, 2019-2027 (USD BILLION)
TABLE 115. ASIA-PACIFIC AUTOIMMUNE TREATMENT MARKET SIZE, BY APPLICATION, 2019-2027 (USD BILLION)
TABLE 116. AUSTRALIA AUTOIMMUNE TREATMENT MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 117. AUSTRALIA AUTOIMMUNE TREATMENT MARKET SIZE, BY PRODUCT, 2019-2027 (USD BILLION)
TABLE 118. AUSTRALIA AUTOIMMUNE TREATMENT MARKET SIZE, BY APPLICATION, 2019-2027 (USD BILLION)
TABLE 119. CHINA AUTOIMMUNE TREATMENT MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 120. CHINA AUTOIMMUNE TREATMENT MARKET SIZE, BY PRODUCT, 2019-2027 (USD BILLION)
TABLE 121. CHINA AUTOIMMUNE TREATMENT MARKET SIZE, BY APPLICATION, 2019-2027 (USD BILLION)
TABLE 122. INDIA AUTOIMMUNE TREATMENT MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 123. INDIA AUTOIMMUNE TREATMENT MARKET SIZE, BY PRODUCT, 2019-2027 (USD BILLION)
TABLE 124. INDIA AUTOIMMUNE TREATMENT MARKET SIZE, BY APPLICATION, 2019-2027 (USD BILLION)
TABLE 125. INDONESIA AUTOIMMUNE TREATMENT MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 126. INDONESIA AUTOIMMUNE TREATMENT MARKET SIZE, BY PRODUCT, 2019-2027 (USD BILLION)
TABLE 127. INDONESIA AUTOIMMUNE TREATMENT MARKET SIZE, BY APPLICATION, 2019-2027 (USD BILLION)
TABLE 128. JAPAN AUTOIMMUNE TREATMENT MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 129. JAPAN AUTOIMMUNE TREATMENT MARKET SIZE, BY PRODUCT, 2019-2027 (USD BILLION)
TABLE 130. JAPAN AUTOIMMUNE TREATMENT MARKET SIZE, BY APPLICATION, 2019-2027 (USD BILLION)
TABLE 131. MALAYSIA AUTOIMMUNE TREATMENT MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 132. MALAYSIA AUTOIMMUNE TREATMENT MARKET SIZE, BY PRODUCT, 2019-2027 (USD BILLION)
TABLE 133. MALAYSIA AUTOIMMUNE TREATMENT MARKET SIZE, BY APPLICATION, 2019-2027 (USD BILLION)
TABLE 134. PHILIPPINES AUTOIMMUNE TREATMENT MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 135. PHILIPPINES AUTOIMMUNE TREATMENT MARKET SIZE, BY PRODUCT, 2019-2027 (USD BILLION)
TABLE 136. PHILIPPINES AUTOIMMUNE TREATMENT MARKET SIZE, BY APPLICATION, 2019-2027 (USD BILLION)
TABLE 137. SINGAPORE AUTOIMMUNE TREATMENT MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 138. SINGAPORE AUTOIMMUNE TREATMENT MARKET SIZE, BY PRODUCT, 2019-2027 (USD BILLION)
TABLE 139. SINGAPORE AUTOIMMUNE TREATMENT MARKET SIZE, BY APPLICATION, 2019-2027 (USD BILLION)
TABLE 140. SOUTH KOREA AUTOIMMUNE TREATMENT MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 141. SOUTH KOREA AUTOIMMUNE TREATMENT MARKET SIZE, BY PRODUCT, 2019-2027 (USD BILLION)
TABLE 142. SOUTH KOREA AUTOIMMUNE TREATMENT MARKET SIZE, BY APPLICATION, 2019-2027 (USD BILLION)
TABLE 143. TAIWAN AUTOIMMUNE TREATMENT MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 144. TAIWAN AUTOIMMUNE TREATMENT MARKET SIZE, BY PRODUCT, 2019-2027 (USD BILLION)
TABLE 145. TAIWAN AUTOIMMUNE TREATMENT MARKET SIZE, BY APPLICATION, 2019-2027 (USD BILLION)
TABLE 146. THAILAND AUTOIMMUNE TREATMENT MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 147. THAILAND AUTOIMMUNE TREATMENT MARKET SIZE, BY PRODUCT, 2019-2027 (USD BILLION)
TABLE 148. THAILAND AUTOIMMUNE TREATMENT MARKET SIZE, BY APPLICATION, 2019-2027 (USD BILLION)
TABLE 149. EUROPE, MIDDLE EAST & AFRICA AUTOIMMUNE TREATMENT MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 150. EUROPE, MIDDLE EAST & AFRICA AUTOIMMUNE TREATMENT MARKET SIZE, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 151. EUROPE, MIDDLE EAST & AFRICA AUTOIMMUNE TREATMENT MARKET SIZE, BY PRODUCT, 2019-2027 (USD BILLION)
TABLE 152. EUROPE, MIDDLE EAST & AFRICA AUTOIMMUNE TREATMENT MARKET SIZE, BY APPLICATION, 2019-2027 (USD BILLION)
TABLE 153. FRANCE AUTOIMMUNE TREATMENT MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 154. FRANCE AUTOIMMUNE TREATMENT MARKET SIZE, BY PRODUCT, 2019-2027 (USD BILLION)
TABLE 155. FRANCE AUTOIMMUNE TREATMENT MARKET SIZE, BY APPLICATION, 2019-2027 (USD BILLION)
TABLE 156. GERMANY AUTOIMMUNE TREATMENT MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 157. GERMANY AUTOIMMUNE TREATMENT MARKET SIZE, BY PRODUCT, 2019-2027 (USD BILLION)
TABLE 158. GERMANY AUTOIMMUNE TREATMENT MARKET SIZE, BY APPLICATION, 2019-2027 (USD BILLION)
TABLE 159. ITALY AUTOIMMUNE TREATMENT MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 160. ITALY AUTOIMMUNE TREATMENT MARKET SIZE, BY PRODUCT, 2019-2027 (USD BILLION)
TABLE 161. ITALY AUTOIMMUNE TREATMENT MARKET SIZE, BY APPLICATION, 2019-2027 (USD BILLION)
TABLE 162. NETHERLANDS AUTOIMMUNE TREATMENT MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 163. NETHERLANDS AUTOIMMUNE TREATMENT MARKET SIZE, BY PRODUCT, 2019-2027 (USD BILLION)
TABLE 164. NETHERLANDS AUTOIMMUNE TREATMENT MARKET SIZE, BY APPLICATION, 2019-2027 (USD BILLION)
TABLE 165. QATAR AUTOIMMUNE TREATMENT MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 166. QATAR AUTOIMMUNE TREATMENT MARKET SIZE, BY PRODUCT, 2019-2027 (USD BILLION)
TABLE 167. QATAR AUTOIMMUNE TREATMENT MARKET SIZE, BY APPLICATION, 2019-2027 (USD BILLION)
TABLE 168. RUSSIA AUTOIMMUNE TREATMENT MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 169. RUSSIA AUTOIMMUNE TREATMENT MARKET SIZE, BY PRODUCT, 2019-2027 (USD BILLION)
TABLE 170. RUSSIA AUTOIMMUNE TREATMENT MARKET SIZE, BY APPLICATION, 2019-2027 (USD BILLION)
TABLE 171. SAUDI ARABIA AUTOIMMUNE TREATMENT MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 172. SAUDI ARABIA AUTOIMMUNE TREATMENT MARKET SIZE, BY PRODUCT, 2019-2027 (USD BILLION)
TABLE 173. SAUDI ARABIA AUTOIMMUNE TREATMENT MARKET SIZE, BY APPLICATION, 2019-2027 (USD BILLION)
TABLE 174. SOUTH AFRICA AUTOIMMUNE TREATMENT MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 175. SOUTH AFRICA AUTOIMMUNE TREATMENT MARKET SIZE, BY PRODUCT, 2019-2027 (USD BILLION)
TABLE 176. SOUTH AFRICA AUTOIMMUNE TREATMENT MARKET SIZE, BY APPLICATION, 2019-2027 (USD BILLION)
TABLE 177. SPAIN AUTOIMMUNE TREATMENT MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 178. SPAIN AUTOIMMUNE TREATMENT MARKET SIZE, BY PRODUCT, 2019-2027 (USD BILLION)
TABLE 179. SPAIN AUTOIMMUNE TREATMENT MARKET SIZE, BY APPLICATION, 2019-2027 (USD BILLION)
TABLE 180. UNITED ARAB EMIRATES AUTOIMMUNE TREATMENT MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 181. UNITED ARAB EMIRATES AUTOIMMUNE TREATMENT MARKET SIZE, BY PRODUCT, 2019-2027 (USD BILLION)
TABLE 182. UNITED ARAB EMIRATES AUTOIMMUNE TREATMENT MARKET SIZE, BY APPLICATION, 2019-2027 (USD BILLION)
TABLE 183. UNITED KINGDOM AUTOIMMUNE TREATMENT MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 184. UNITED KINGDOM AUTOIMMUNE TREATMENT MARKET SIZE, BY PRODUCT, 2019-2027 (USD BILLION)
TABLE 185. UNITED KINGDOM AUTOIMMUNE TREATMENT MARKET SIZE, BY APPLICATION, 2019-2027 (USD BILLION)
TABLE 186. GLOBAL AUTOIMMUNE TREATMENT MARKET: FPNV POSITIONING MATRIX - SCORES, 2021
TABLE 187. GLOBAL AUTOIMMUNE TREATMENT MARKET: FPNV POSITIONING MATRIX - BUSINESS STRATEGY, 2021
TABLE 188. GLOBAL AUTOIMMUNE TREATMENT MARKET: FPNV POSITIONING MATRIX - PRODUCT SATISFACTION, 2021
TABLE 189. GLOBAL AUTOIMMUNE TREATMENT MARKET RANKING
TABLE 190. GLOBAL AUTOIMMUNE TREATMENT MARKET SHARE, BY KEY PLAYER, 2021
TABLE 191. GLOBAL AUTOIMMUNE TREATMENT MARKET MERGER & ACQUISITION
TABLE 192. GLOBAL AUTOIMMUNE TREATMENT MARKET AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 193. GLOBAL AUTOIMMUNE TREATMENT MARKET NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 194. GLOBAL AUTOIMMUNE TREATMENT MARKET INVESTMENT & FUNDING
TABLE 195. GLOBAL AUTOIMMUNE TREATMENT MARKET AWARD, RECOGNITION, & EXPANSION
TABLE 196. GLOBAL AUTOIMMUNE TREATMENT MARKET: LICENSE & PRICING

Companies Mentioned

  • Abbott Laboratories
  • AbbVie Inc
  • Active Biotech
  • Amgen Inc.
  • Angiotech Pharmaceuticals
  • Astellas Pharma Inc
  • AstraZeneca PLC
  • Autoimmune Inc
  • Bayer AG
  • Bio-rad Laboratories
  • Biocryst Pharmaceuticals Inc.
  • Biogen Inc
  • Biomérieux SA
  • Bristol-Myers Squibb
  • C.H. Boehringer Sohn AG & Ko. KG
  • F. Hoffmann-la Roche
  • GlaxoSmithKline PLC
  • Inova Diagnostics, Inc. by Werfen Group
  • Johnson & Johnson Services, Inc
  • Lupin Limited
  • Myriad Genetics
  • Novartis AG
  • Pandion Therapeutics
  • Pfizer Inc.
  • SC AG
  • Siemens Healthineers, Inc.
  • Thermo Fisher Scientific, Inc
  • Trinity Biotech PLC

Methodology

Loading
LOADING...